CS logo
small CS logo
Institut de Cardiologie de la Pitié-Salpêtrière

Paris, France
Heart hospital in Paris
47-83 Bd de l'Hôpital, 75013 Paris

About Institut de Cardiologie de la Pitié-Salpêtrière


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Institut de Cardiologie de la Pitié-Salpêtrière


During the past decade, Institut de Cardiologie de la Pitié-Salpêtrière conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Institut de Cardiologie de la Pitié-Salpêtrière" #1 collaborator was "Action Research Group" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Fédération Française de Cardiologie" with 1 trials as a collaborator and "Groupe Hospitalier Pitie-Salpetriere" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

Clinical Trials Conditions at Institut de Cardiologie de la Pitié-Salpêtrière


According to Clinical.Site data, the most researched conditions in "Institut de Cardiologie de la Pitié-Salpêtrière" are "Atrial Fibrillation" (3 trials), "Coronary Artery Disease" (3 trials), "Myocardial Infarction" (3 trials), "Myocardial Ischemia" (2 trials) and "Stent Thrombosis" (2 trials). Many other conditions were trialed in "Institut de Cardiologie de la Pitié-Salpêtrière" in a lesser frequency.

Clinical Trials Intervention Types at Institut de Cardiologie de la Pitié-Salpêtrière


Most popular intervention types in "Institut de Cardiologie de la Pitié-Salpêtrière" are "Drug" (8 trials), "Biological" (1 trials), "Device" (1 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Aspirin" (2 trials), "Dabigatran Etexilate 150mg" (2 trials), "Aspirin and Clopidogrel" (1 trials), "Beta-blockers withdrawal" (1 trials) and "Catheterization immediate PCI" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Institut de Cardiologie de la Pitié-Salpêtrière


The vast majority of trials in "Institut de Cardiologie de la Pitié-Salpêtrière" are 11 trials for "All" genders and 1 trials for "Male" genders.

Clinical Trials Status at Institut de Cardiologie de la Pitié-Salpêtrière


Currently, there are NaN active trials in "Institut de Cardiologie de la Pitié-Salpêtrière". 2 are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Institut de Cardiologie de la Pitié-Salpêtrière, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Institut de Cardiologie de la Pitié-Salpêtrière, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".